MedKoo Cat#: 562133 | Name: Monoelaidin
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Monoelaidin is an enhancer of the solubility and oral bioavailability for poorly water-soluble drugs.

Chemical Structure

Monoelaidin
Monoelaidin
CAS#2716-53-2

Theoretical Analysis

MedKoo Cat#: 562133

Name: Monoelaidin

CAS#: 2716-53-2

Chemical Formula: C21H40O4

Exact Mass: 356.2927

Molecular Weight: 356.55

Elemental Analysis: C, 70.74; H, 11.31; O, 17.95

Price and Availability

Size Price Availability Quantity
250mg USD 260.00
1g USD 520.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Monoelaidin;
IUPAC/Chemical Name
2,3-Dihydroxypropyl (E)-octadec-9-enoate
InChi Key
RZRNAYUHWVFMIP-MDZDMXLPSA-N
InChi Code
InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9+
SMILES Code
CCCCCCCC/C=C/CCCCCCCC(OCC(O)CO)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Monoelaidin is an enhancer of the solubility and oral bioavailability for poorly water-soluble drugs.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 356.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Milak S, Zimmer A. Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm. 2015 Jan 30;478(2):569-87. doi: 10.1016/j.ijpharm.2014.11.072. Epub 2014 Dec 3. Review. PubMed PMID: 25479099. 2: Kulkarni CV. Lipid crystallization: from self-assembly to hierarchical and biological ordering. Nanoscale. 2012 Sep 28;4(19):5779-91. doi: 10.1039/c2nr31465g. Epub 2012 Aug 16. Review. PubMed PMID: 22899223. 3: Garg G, Saraf S, Saraf S. Cubosomes: an overview. Biol Pharm Bull. 2007 Feb;30(2):350-3. Review. PubMed PMID: 17268078. 4: Kocherbitov V. Driving forces of phase transitions in surfactant and lipid systems. J Phys Chem B. 2005 Apr 7;109(13):6430-5. Review. PubMed PMID: 16851716. 5: Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):229-50. Review. PubMed PMID: 11311994. 6: Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm. 2000 Aug;26(8):809-20. Review. PubMed PMID: 10900537.